Javascript doit fonctionner ! Activez-le et rechargez cette page.
Le Rézo de JeuxDeMots
• Types de relations
• Types de noeuds
• Consolider
le terme
  Options  
             

  Filtrage type relations : +   - (ex: 4, 12, 18, 36, 444, 555, 777)
  Filtrage valeur :          min   max
  Filtrage type noeuds :   +   - (ex: 4, 6, 8, 9, 10, 12, 18, 36, 444, 555, 777)

  Présentation de sortie :   (ex: -rien-, cloud, nicecloud)
 

'en:properdin'
(id=7108997 ; fe=en:properdin ; type=1 ; niveau=200 ; luminosité=25 ; somme entrante=2186 creation date=2017-06-25 touchdate=2025-12-02 05:06:19.000)
≈ 64 relations sortantes

  1. en:properdin -- r_associated #0: 131 / 1 -> biologie
    n1=en:properdin | n2=biologie | rel=r_associated | relid=0 | w=131
  2. en:properdin -- r_associated #0: 131 / 1 -> chimie
    n1=en:properdin | n2=chimie | rel=r_associated | relid=0 | w=131
  3. en:properdin -- r_associated #0: 60 / 0.458 -> en:beta globulin
    n1=en:properdin | n2=en:beta globulin | rel=r_associated | relid=0 | w=60
  4. en:properdin -- r_associated #0: 60 / 0.458 -> en:hemopexin
    n1=en:properdin | n2=en:hemopexin | rel=r_associated | relid=0 | w=60
  5. en:properdin -- r_associated #0: 60 / 0.458 -> protéine
    n1=en:properdin | n2=protéine | rel=r_associated | relid=0 | w=60
  6. en:properdin -- r_associated #0: 59 / 0.45 -> en:peptide p (properdin)
    n1=en:properdin | n2=en:peptide p (properdin) | rel=r_associated | relid=0 | w=59
  7. en:properdin -- r_associated #0: 57 / 0.435 -> en:beta-2-microglobulin protein
    n1=en:properdin | n2=en:beta-2-microglobulin protein | rel=r_associated | relid=0 | w=57
  8. en:properdin -- r_associated #0: 57 / 0.435 -> en:properdin deficiency, type ii
    n1=en:properdin | n2=en:properdin deficiency, type ii | rel=r_associated | relid=0 | w=57
  9. en:properdin -- r_associated #0: 57 / 0.435 -> en:properdin deficiency, x-linked
    n1=en:properdin | n2=en:properdin deficiency, x-linked | rel=r_associated | relid=0 | w=57
  10. en:properdin -- r_associated #0: 57 / 0.435 -> PROPELLER (séquence IRM)
    n1=en:properdin | n2=PROPELLER (séquence IRM) | rel=r_associated | relid=0 | w=57
  11. en:properdin -- r_associated #0: 50 / 0.382 -> en:complement activating enzymes
    n1=en:properdin | n2=en:complement activating enzymes | rel=r_associated | relid=0 | w=50
  12. en:properdin -- r_associated #0: 50 / 0.382 -> en:complement c1q subcomponent subunit a
    n1=en:properdin | n2=en:complement c1q subcomponent subunit a | rel=r_associated | relid=0 | w=50
  13. en:properdin -- r_associated #0: 49 / 0.374 -> en:complement inactivator proteins
    n1=en:properdin | n2=en:complement inactivator proteins | rel=r_associated | relid=0 | w=49
  14. en:properdin -- r_associated #0: 48 / 0.366 -> en:tuftsin
    n1=en:properdin | n2=en:tuftsin | rel=r_associated | relid=0 | w=48
  15. en:properdin -- r_associated #0: 47 / 0.359 -> en:complement component c7
    n1=en:properdin | n2=en:complement component c7 | rel=r_associated | relid=0 | w=47
  16. en:properdin -- r_associated #0: 38 / 0.29 -> en:complement component c1
    n1=en:properdin | n2=en:complement component c1 | rel=r_associated | relid=0 | w=38
  17. en:properdin -- r_associated #0: 35 / 0.267 -> c79 protéines régulatrices du plasma
    n1=en:properdin | n2=c79 protéines régulatrices du plasma | rel=r_associated | relid=0 | w=35
  18. en:properdin -- r_associated #0: 35 / 0.267 -> en:plasma regulatory protein
    n1=en:properdin | n2=en:plasma regulatory protein | rel=r_associated | relid=0 | w=35
  19. en:properdin -- r_associated #0: 32 / 0.244 -> en:complement component-4
    n1=en:properdin | n2=en:complement component-4 | rel=r_associated | relid=0 | w=32
  20. en:properdin -- r_associated #0: 30 / 0.229 -> composant du complément de la properdine
    n1=en:properdin | n2=composant du complément de la properdine | rel=r_associated | relid=0 | w=30
  21. en:properdin -- r_associated #0: 30 / 0.229 -> en:complement c5
    n1=en:properdin | n2=en:complement c5 | rel=r_associated | relid=0 | w=30
  22. en:properdin -- r_associated #0: 30 / 0.229 -> en:complement factor b
    n1=en:properdin | n2=en:complement factor b | rel=r_associated | relid=0 | w=30
  23. en:properdin -- r_associated #0: 30 / 0.229 -> en:serotransferrin
    n1=en:properdin | n2=en:serotransferrin | rel=r_associated | relid=0 | w=30
  24. en:properdin -- r_associated #0: 30 / 0.229 -> facteur p du complément
    n1=en:properdin | n2=facteur p du complément | rel=r_associated | relid=0 | w=30
  25. en:properdin -- r_associated #0: 29 / 0.221 -> en:deficiency aspects
    n1=en:properdin | n2=en:deficiency aspects | rel=r_associated | relid=0 | w=29
  26. en:properdin -- r_associated #0: 28 / 0.214 -> en:complement c3
    n1=en:properdin | n2=en:complement c3 | rel=r_associated | relid=0 | w=28
  27. en:properdin -- r_associated #0: 28 / 0.214 -> en:mechanism of action qualifier
    n1=en:properdin | n2=en:mechanism of action qualifier | rel=r_associated | relid=0 | w=28
  28. en:properdin -- r_associated #0: 27 / 0.206 -> en:complement c4-b
    n1=en:properdin | n2=en:complement c4-b | rel=r_associated | relid=0 | w=27
  29. en:properdin -- r_associated #0: 27 / 0.206 -> properdine
    n1=en:properdin | n2=properdine | rel=r_associated | relid=0 | w=27
  30. en:properdin -- r_associated #0: 25 / 0.191 -> en:complement c4-a
    n1=en:properdin | n2=en:complement c4-a | rel=r_associated | relid=0 | w=25
  31. en:properdin -- r_associated #0: 25 / 0.191 -> en:standards characteristics
    n1=en:properdin | n2=en:standards characteristics | rel=r_associated | relid=0 | w=25
  32. en:properdin -- r_associated #0: 24 / 0.183 -> en:bioformation
    n1=en:properdin | n2=en:bioformation | rel=r_associated | relid=0 | w=24
  33. en:properdin -- r_associated #0: 24 / 0.183 -> en:c6 inactivator
    n1=en:properdin | n2=en:c6 inactivator | rel=r_associated | relid=0 | w=24
  34. en:properdin -- r_associated #0: 24 / 0.183 -> en:complement c2
    n1=en:properdin | n2=en:complement c2 | rel=r_associated | relid=0 | w=24
  35. en:properdin -- r_associated #0: 24 / 0.183 -> en:therapeutic use - qualifier
    n1=en:properdin | n2=en:therapeutic use - qualifier | rel=r_associated | relid=0 | w=24
  36. en:properdin -- r_associated #0: 23 / 0.176 -> en:complement component 9
    n1=en:properdin | n2=en:complement component 9 | rel=r_associated | relid=0 | w=23
  37. en:properdin -- r_associated #0: 23 / 0.176 -> en:physiological aspects
    n1=en:properdin | n2=en:physiological aspects | rel=r_associated | relid=0 | w=23
  38. en:properdin -- r_associated #0: 22 / 0.168 -> en:agonists
    n1=en:properdin | n2=en:agonists | rel=r_associated | relid=0 | w=22
  39. en:properdin -- r_associated #0: 22 / 0.168 -> en:complement component c8
    n1=en:properdin | n2=en:complement component c8 | rel=r_associated | relid=0 | w=22
  40. en:properdin -- r_associated #0: 22 / 0.168 -> en:drug effect
    n1=en:properdin | n2=en:drug effect | rel=r_associated | relid=0 | w=22
  41. en:properdin -- r_associated #0: 21 / 0.16 -> en:c4d
    n1=en:properdin | n2=en:c4d | rel=r_associated | relid=0 | w=21
  42. en:properdin -- r_associated #0: 21 / 0.16 -> en:complement component c6
    n1=en:properdin | n2=en:complement component c6 | rel=r_associated | relid=0 | w=21
  43. en:properdin -- r_associated #0: 21 / 0.16 -> en:pharmacokinetic aspects
    n1=en:properdin | n2=en:pharmacokinetic aspects | rel=r_associated | relid=0 | w=21
  44. en:properdin -- r_associated #0: 20 / 0.153 -> anaphylatoxines
    n1=en:properdin | n2=anaphylatoxines | rel=r_associated | relid=0 | w=20
  45. en:properdin -- r_associated #0: 20 / 0.153 -> effet d'un médicament
    n1=en:properdin | n2=effet d'un médicament | rel=r_associated | relid=0 | w=20
  46. en:properdin -- r_associated #0: 20 / 0.153 -> en:alternative complement pathway
    n1=en:properdin | n2=en:alternative complement pathway | rel=r_associated | relid=0 | w=20
  47. en:properdin -- r_associated #0: 20 / 0.153 -> en:anaphylatoxins
    n1=en:properdin | n2=en:anaphylatoxins | rel=r_associated | relid=0 | w=20
  48. en:properdin -- r_associated #0: 20 / 0.153 -> en:beta-2 globulin
    n1=en:properdin | n2=en:beta-2 globulin | rel=r_associated | relid=0 | w=20
  49. en:properdin -- r_associated #0: 20 / 0.153 -> en:c>5b67< inhibitor
    n1=en:properdin | n2=en:c>5b67< inhibitor | rel=r_associated | relid=0 | w=20
  50. en:properdin -- r_associated #0: 20 / 0.153 -> en:c1r: c1s: c1 - complement component 1r: complement component 1s: complement component 1 inhibitor activation complex
    n1=en:properdin | n2=en:c1r: c1s: c1 - complement component 1r: complement component 1s: complement component 1 inhibitor activation complex | rel=r_associated | relid=0 | w=20
  51. en:properdin -- r_associated #0: 20 / 0.153 -> en:c3(h20)bb
    n1=en:properdin | n2=en:c3(h20)bb | rel=r_associated | relid=0 | w=20
  52. en:properdin -- r_associated #0: 20 / 0.153 -> en:complement allotype
    n1=en:properdin | n2=en:complement allotype | rel=r_associated | relid=0 | w=20
  53. en:properdin -- r_associated #0: 20 / 0.153 -> en:complement c3, human
    n1=en:properdin | n2=en:complement c3, human | rel=r_associated | relid=0 | w=20
  54. en:properdin -- r_associated #0: 20 / 0.153 -> en:complement component c1r2c1s2
    n1=en:properdin | n2=en:complement component c1r2c1s2 | rel=r_associated | relid=0 | w=20
  55. en:properdin -- r_associated #0: 20 / 0.153 -> en:complement factor d, human
    n1=en:properdin | n2=en:complement factor d, human | rel=r_associated | relid=0 | w=20
  56. en:properdin -- r_associated #0: 20 / 0.153 -> en:complement factor h-related protein 1, human
    n1=en:properdin | n2=en:complement factor h-related protein 1, human | rel=r_associated | relid=0 | w=20
  57. en:properdin -- r_associated #0: 20 / 0.153 -> en:complement factor h, human
    n1=en:properdin | n2=en:complement factor h, human | rel=r_associated | relid=0 | w=20
  58. en:properdin -- r_associated #0: 20 / 0.153 -> en:complement receptor type 1
    n1=en:properdin | n2=en:complement receptor type 1 | rel=r_associated | relid=0 | w=20
  59. en:properdin -- r_associated #0: 20 / 0.153 -> en:complement regulatory factor
    n1=en:properdin | n2=en:complement regulatory factor | rel=r_associated | relid=0 | w=20
  60. en:properdin -- r_associated #0: 20 / 0.153 -> en:extracellular space
    n1=en:properdin | n2=en:extracellular space | rel=r_associated | relid=0 | w=20
  61. en:properdin -- r_associated #0: 20 / 0.153 -> en:properdin convertase, complement component
    n1=en:properdin | n2=en:properdin convertase, complement component | rel=r_associated | relid=0 | w=20
  62. en:properdin -- r_associated #0: 20 / 0.153 -> en:properdin deficiency, type iii
    n1=en:properdin | n2=en:properdin deficiency, type iii | rel=r_associated | relid=0 | w=20
  63. en:properdin -- r_associated #0: 20 / 0.153 -> en:properdin native
    n1=en:properdin | n2=en:properdin native | rel=r_associated | relid=0 | w=20
  64. en:properdin -- r_associated #0: 2 / 0.015 -> en:amino acid, peptide, or protein
    n1=en:properdin | n2=en:amino acid, peptide, or protein | rel=r_associated | relid=0 | w=2
≈ 68 relations entrantes

  1. effet d'un médicament --- r_associated #0: 52 --> en:properdin
    n1=effet d'un médicament | n2=en:properdin | rel=r_associated | relid=0 | w=52
  2. en:drug effect --- r_associated #0: 49 --> en:properdin
    n1=en:drug effect | n2=en:properdin | rel=r_associated | relid=0 | w=49
  3. en:complement factor h, human --- r_associated #0: 42 --> en:properdin
    n1=en:complement factor h, human | n2=en:properdin | rel=r_associated | relid=0 | w=42
  4. en:agonists --- r_associated #0: 35 --> en:properdin
    n1=en:agonists | n2=en:properdin | rel=r_associated | relid=0 | w=35
  5. en:alternative complement pathway --- r_associated #0: 35 --> en:properdin
    n1=en:alternative complement pathway | n2=en:properdin | rel=r_associated | relid=0 | w=35
  6. en:anaphylatoxins --- r_associated #0: 35 --> en:properdin
    n1=en:anaphylatoxins | n2=en:properdin | rel=r_associated | relid=0 | w=35
  7. en:bioformation --- r_associated #0: 35 --> en:properdin
    n1=en:bioformation | n2=en:properdin | rel=r_associated | relid=0 | w=35
  8. en:complement c4-b --- r_associated #0: 35 --> en:properdin
    n1=en:complement c4-b | n2=en:properdin | rel=r_associated | relid=0 | w=35
  9. en:complement component c1 --- r_associated #0: 35 --> en:properdin
    n1=en:complement component c1 | n2=en:properdin | rel=r_associated | relid=0 | w=35
  10. en:complement component c7 --- r_associated #0: 35 --> en:properdin
    n1=en:complement component c7 | n2=en:properdin | rel=r_associated | relid=0 | w=35
  11. en:complement component c8 --- r_associated #0: 35 --> en:properdin
    n1=en:complement component c8 | n2=en:properdin | rel=r_associated | relid=0 | w=35
  12. en:complement receptor type 1 --- r_associated #0: 35 --> en:properdin
    n1=en:complement receptor type 1 | n2=en:properdin | rel=r_associated | relid=0 | w=35
  13. en:properdin convertase, complement component --- r_associated #0: 35 --> en:properdin
    n1=en:properdin convertase, complement component | n2=en:properdin | rel=r_associated | relid=0 | w=35
  14. properdine --- r_associated #0: 35 --> en:properdin
    n1=properdine | n2=en:properdin | rel=r_associated | relid=0 | w=35
  15. PROPELLER (séquence IRM) --- r_associated #0: 34 --> en:properdin
    n1=PROPELLER (séquence IRM) | n2=en:properdin | rel=r_associated | relid=0 | w=34
  16. anaphylatoxines --- r_associated #0: 34 --> en:properdin
    n1=anaphylatoxines | n2=en:properdin | rel=r_associated | relid=0 | w=34
  17. c79 protéines régulatrices du plasma --- r_associated #0: 34 --> en:properdin
    n1=c79 protéines régulatrices du plasma | n2=en:properdin | rel=r_associated | relid=0 | w=34
  18. en:c3(h20)bb --- r_associated #0: 34 --> en:properdin
    n1=en:c3(h20)bb | n2=en:properdin | rel=r_associated | relid=0 | w=34
  19. en:c>5b67< inhibitor --- r_associated #0: 34 --> en:properdin
    n1=en:c>5b67< inhibitor | n2=en:properdin | rel=r_associated | relid=0 | w=34
  20. en:complement c2 --- r_associated #0: 34 --> en:properdin
    n1=en:complement c2 | n2=en:properdin | rel=r_associated | relid=0 | w=34
  21. en:complement component 9 --- r_associated #0: 34 --> en:properdin
    n1=en:complement component 9 | n2=en:properdin | rel=r_associated | relid=0 | w=34
  22. en:c4d --- r_associated #0: 32 --> en:properdin
    n1=en:c4d | n2=en:properdin | rel=r_associated | relid=0 | w=32
  23. en:c6 inactivator --- r_associated #0: 32 --> en:properdin
    n1=en:c6 inactivator | n2=en:properdin | rel=r_associated | relid=0 | w=32
  24. en:complement c1q subcomponent subunit a --- r_associated #0: 32 --> en:properdin
    n1=en:complement c1q subcomponent subunit a | n2=en:properdin | rel=r_associated | relid=0 | w=32
  25. en:complement c3, human --- r_associated #0: 32 --> en:properdin
    n1=en:complement c3, human | n2=en:properdin | rel=r_associated | relid=0 | w=32
  26. en:complement component c6 --- r_associated #0: 32 --> en:properdin
    n1=en:complement component c6 | n2=en:properdin | rel=r_associated | relid=0 | w=32
  27. en:complement regulatory factor --- r_associated #0: 32 --> en:properdin
    n1=en:complement regulatory factor | n2=en:properdin | rel=r_associated | relid=0 | w=32
  28. en:deficiency aspects --- r_associated #0: 32 --> en:properdin
    n1=en:deficiency aspects | n2=en:properdin | rel=r_associated | relid=0 | w=32
  29. en:complement c4-a --- r_associated #0: 31 --> en:properdin
    n1=en:complement c4-a | n2=en:properdin | rel=r_associated | relid=0 | w=31
  30. en:complement c5 --- r_associated #0: 31 --> en:properdin
    n1=en:complement c5 | n2=en:properdin | rel=r_associated | relid=0 | w=31
  31. en:complement factor d, human --- r_associated #0: 31 --> en:properdin
    n1=en:complement factor d, human | n2=en:properdin | rel=r_associated | relid=0 | w=31
  32. en:extracellular space --- r_associated #0: 31 --> en:properdin
    n1=en:extracellular space | n2=en:properdin | rel=r_associated | relid=0 | w=31
  33. en:properdin deficiency, type ii --- r_associated #0: 31 --> en:properdin
    n1=en:properdin deficiency, type ii | n2=en:properdin | rel=r_associated | relid=0 | w=31
  34. voie alterne du complément --- r_associated #0: 31 --> en:properdin
    n1=voie alterne du complément | n2=en:properdin | rel=r_associated | relid=0 | w=31
  35. en:complement component c1r2c1s2 --- r_associated #0: 30 --> en:properdin
    n1=en:complement component c1r2c1s2 | n2=en:properdin | rel=r_associated | relid=0 | w=30
  36. en:mechanism of action qualifier --- r_associated #0: 30 --> en:properdin
    n1=en:mechanism of action qualifier | n2=en:properdin | rel=r_associated | relid=0 | w=30
  37. en:pharmacokinetic aspects --- r_associated #0: 30 --> en:properdin
    n1=en:pharmacokinetic aspects | n2=en:properdin | rel=r_associated | relid=0 | w=30
  38. en:properdin deficiency, type iii --- r_associated #0: 30 --> en:properdin
    n1=en:properdin deficiency, type iii | n2=en:properdin | rel=r_associated | relid=0 | w=30
  39. en:physiological aspects --- r_associated #0: 29 --> en:properdin
    n1=en:physiological aspects | n2=en:properdin | rel=r_associated | relid=0 | w=29
  40. en:properdin native --- r_associated #0: 29 --> en:properdin
    n1=en:properdin native | n2=en:properdin | rel=r_associated | relid=0 | w=29
  41. en:beta-2 globulin --- r_associated #0: 28 --> en:properdin
    n1=en:beta-2 globulin | n2=en:properdin | rel=r_associated | relid=0 | w=28
  42. en:c1r: c1s: c1 - complement component 1r: complement component 1s: complement component 1 inhibitor activation complex --- r_associated #0: 28 --> en:properdin
    n1=en:c1r: c1s: c1 - complement component 1r: complement component 1s: complement component 1 inhibitor activation complex | n2=en:properdin | rel=r_associated | relid=0 | w=28
  43. en:complement c3 --- r_associated #0: 28 --> en:properdin
    n1=en:complement c3 | n2=en:properdin | rel=r_associated | relid=0 | w=28
  44. en:beta-2-microglobulin protein --- r_associated #0: 27 --> en:properdin
    n1=en:beta-2-microglobulin protein | n2=en:properdin | rel=r_associated | relid=0 | w=27
  45. en:complement allotype --- r_associated #0: 27 --> en:properdin
    n1=en:complement allotype | n2=en:properdin | rel=r_associated | relid=0 | w=27
  46. en:standards characteristics --- r_associated #0: 27 --> en:properdin
    n1=en:standards characteristics | n2=en:properdin | rel=r_associated | relid=0 | w=27
  47. composant du complément de la properdine --- r_associated #0: 26 --> en:properdin
    n1=composant du complément de la properdine | n2=en:properdin | rel=r_associated | relid=0 | w=26
  48. en:complement factor h-related protein 1, human --- r_associated #0: 26 --> en:properdin
    n1=en:complement factor h-related protein 1, human | n2=en:properdin | rel=r_associated | relid=0 | w=26
  49. en:therapeutic use - qualifier --- r_associated #0: 26 --> en:properdin
    n1=en:therapeutic use - qualifier | n2=en:properdin | rel=r_associated | relid=0 | w=26
  50. facteur p du complément --- r_associated #0: 26 --> en:properdin
    n1=facteur p du complément | n2=en:properdin | rel=r_associated | relid=0 | w=26
  51. en:beta globulin --- r_associated #0: 20 --> en:properdin
    n1=en:beta globulin | n2=en:properdin | rel=r_associated | relid=0 | w=20
  52. en:complement activating enzymes --- r_associated #0: 20 --> en:properdin
    n1=en:complement activating enzymes | n2=en:properdin | rel=r_associated | relid=0 | w=20
  53. en:complement component-4 --- r_associated #0: 20 --> en:properdin
    n1=en:complement component-4 | n2=en:properdin | rel=r_associated | relid=0 | w=20
  54. en:complement factor b --- r_associated #0: 20 --> en:properdin
    n1=en:complement factor b | n2=en:properdin | rel=r_associated | relid=0 | w=20
  55. en:complement inactivator proteins --- r_associated #0: 20 --> en:properdin
    n1=en:complement inactivator proteins | n2=en:properdin | rel=r_associated | relid=0 | w=20
  56. en:hemopexin --- r_associated #0: 20 --> en:properdin
    n1=en:hemopexin | n2=en:properdin | rel=r_associated | relid=0 | w=20
  57. en:peptide p (properdin) --- r_associated #0: 20 --> en:properdin
    n1=en:peptide p (properdin) | n2=en:properdin | rel=r_associated | relid=0 | w=20
  58. en:plasma regulatory protein --- r_associated #0: 20 --> en:properdin
    n1=en:plasma regulatory protein | n2=en:properdin | rel=r_associated | relid=0 | w=20
  59. en:properdin deficiency, x-linked --- r_associated #0: 20 --> en:properdin
    n1=en:properdin deficiency, x-linked | n2=en:properdin | rel=r_associated | relid=0 | w=20
  60. en:serotransferrin --- r_associated #0: 20 --> en:properdin
    n1=en:serotransferrin | n2=en:properdin | rel=r_associated | relid=0 | w=20
  61. en:tuftsin --- r_associated #0: 20 --> en:properdin
    n1=en:tuftsin | n2=en:properdin | rel=r_associated | relid=0 | w=20
  62. protéine --- r_associated #0: 20 --> en:properdin
    n1=protéine | n2=en:properdin | rel=r_associated | relid=0 | w=20
  63. propepsine --- r_associated #0: 10 --> en:properdin
    n1=propepsine | n2=en:properdin | rel=r_associated | relid=0 | w=10
  64. prophage --- r_associated #0: 10 --> en:properdin
    n1=prophage | n2=en:properdin | rel=r_associated | relid=0 | w=10
  65. proteine --- r_associated #0: 10 --> en:properdin
    n1=proteine | n2=en:properdin | rel=r_associated | relid=0 | w=10
  66. tuftsine --- r_associated #0: 10 --> en:properdin
    n1=tuftsine | n2=en:properdin | rel=r_associated | relid=0 | w=10
  67. biologie --- r_associated #0: 3 --> en:properdin
    n1=biologie | n2=en:properdin | rel=r_associated | relid=0 | w=3
  68. chimie --- r_associated #0: 3 --> en:properdin
    n1=chimie | n2=en:properdin | rel=r_associated | relid=0 | w=3
Le service Rézo permet d'énumérer les relations existant pour un terme. Ce service est interrogeable par programme.
Projet JeuxDeMots - url: http://www.jeuxdemots.org
contact: mathieu.lafourcade@lirmm.fr